Ghislaine Guillemain

831 total citations
21 papers, 605 citations indexed

About

Ghislaine Guillemain is a scholar working on Surgery, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ghislaine Guillemain has authored 21 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 10 papers in Genetics and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ghislaine Guillemain's work include Pancreatic function and diabetes (13 papers), Diabetes and associated disorders (7 papers) and Endoplasmic Reticulum Stress and Disease (5 papers). Ghislaine Guillemain is often cited by papers focused on Pancreatic function and diabetes (13 papers), Diabetes and associated disorders (7 papers) and Endoplasmic Reticulum Stress and Disease (5 papers). Ghislaine Guillemain collaborates with scholars based in France, Switzerland and United Kingdom. Ghislaine Guillemain's co-authors include B. Blondeau, Armelle Leturque, Bruno Fève, Carine Beaupère, Raphaël Scharfmann, Jean Girard, M. Loizeau, Guy A. Rutter, Gabriela da Silva Xavier and Anne‐Françoise Burnol and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Ghislaine Guillemain

21 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ghislaine Guillemain France 14 299 242 156 125 108 21 605
Kevin Vivot France 14 279 0.9× 275 1.1× 183 1.2× 98 0.8× 113 1.0× 19 625
Robert N. Bone United States 14 285 1.0× 239 1.0× 150 1.0× 158 1.3× 82 0.8× 23 645
Kristin Viste Norway 12 325 1.1× 143 0.6× 129 0.8× 66 0.5× 133 1.2× 22 604
Jelena Kolic Canada 11 333 1.1× 284 1.2× 208 1.3× 87 0.7× 73 0.7× 13 556
Marina Casimir Switzerland 12 335 1.1× 372 1.5× 154 1.0× 177 1.4× 102 0.9× 13 661
Bryndon J. Oleson United States 10 212 0.7× 172 0.7× 75 0.5× 108 0.9× 88 0.8× 22 516
Mindy A. Kendrick United States 16 489 1.6× 470 1.9× 169 1.1× 170 1.4× 202 1.9× 17 805
Russell S. Roberson United States 10 255 0.9× 296 1.2× 115 0.7× 136 1.1× 128 1.2× 13 667
Helen Freeman United Kingdom 5 400 1.3× 217 0.9× 95 0.6× 177 1.4× 232 2.1× 5 744
Yvan Gosmain Switzerland 15 349 1.2× 413 1.7× 216 1.4× 214 1.7× 127 1.2× 20 719

Countries citing papers authored by Ghislaine Guillemain

Since Specialization
Citations

This map shows the geographic impact of Ghislaine Guillemain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ghislaine Guillemain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ghislaine Guillemain more than expected).

Fields of papers citing papers by Ghislaine Guillemain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ghislaine Guillemain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ghislaine Guillemain. The network helps show where Ghislaine Guillemain may publish in the future.

Co-authorship network of co-authors of Ghislaine Guillemain

This figure shows the co-authorship network connecting the top 25 collaborators of Ghislaine Guillemain. A scholar is included among the top collaborators of Ghislaine Guillemain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ghislaine Guillemain. Ghislaine Guillemain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guillemain, Ghislaine, Lucie Khemtémourian, Didier Morin, et al.. (2024). TSPO in pancreatic beta cells and its possible involvement in type 2 diabetes. Biochimie. 224. 104–113. 1 indexed citations
2.
Guillemain, Ghislaine, J Lacapère, & Lucie Khemtémourian. (2022). Targeting hIAPP fibrillation: A new paradigm to prevent β-cell death?. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1864(10). 184002–184002. 9 indexed citations
4.
Buscato, Mélissa, Pierre Gourdy, Jean–François Gautier, et al.. (2018). Adaptive β-Cell Neogenesis in the Adult Mouse in Response to Glucocorticoid-Induced Insulin Resistance. Diabetes. 68(1). 95–108. 24 indexed citations
5.
Khemtémourian, Lucie, Ghislaine Guillemain, Fabienne Foufelle, & J. Antoinette Killian. (2017). Residue specific effects of human islet polypeptide amyloid on self-assembly and on cell toxicity. Biochimie. 142. 22–30. 27 indexed citations
6.
Singh‐Estivalet, Amrit, Jean‐Marie Launay, Jacques Callebert, et al.. (2016). Glucocorticoids Inhibit Basal and Hormone-Induced Serotonin Synthesis in Pancreatic Beta Cells. PLoS ONE. 11(2). e0149343–e0149343. 10 indexed citations
7.
Carrière, Véronique, Kévin Garbin, B. Blondeau, et al.. (2015). Glucose Tolerance Is Improved in Mice Invalidated for the Nuclear Receptor HNF-4γ: A Critical Role for Enteroendocrine Cell Lineage. Diabetes. 64(8). 2744–2756. 19 indexed citations
8.
Guillemain, Ghislaine, Alexandra Grosfeld, Sandrine Vuillaumier‐Barrot, et al.. (2013). Mutations in SLC2A2 Gene Reveal hGLUT2 Function in Pancreatic β Cell Development. Journal of Biological Chemistry. 288(43). 31080–31092. 20 indexed citations
10.
Guillemain, Ghislaine, Gaëlle Filhoulaud, & Raphaël Scharfmann. (2010). THE HEXOSAMINE BIOSYNTHESIS PATHWAY IS ESSENTIAL FOR PANCREATIC BETA CELL DEVELOPMENT. The FASEB Journal. 24(S1). 1 indexed citations
11.
Filhoulaud, Gaëlle, Ghislaine Guillemain, & Raphaël Scharfmann. (2009). The Hexosamine Biosynthesis Pathway Is Essential for Pancreatic Beta Cell Development. Journal of Biological Chemistry. 284(36). 24583–24594. 23 indexed citations
12.
Scharfmann, Raphaël, et al.. (2008). β‐cell development: the role of intercellular signals. Diabetes Obesity and Metabolism. 10(s4). 195–200. 11 indexed citations
13.
Duvillié, Bertrand, et al.. (2008). Control of pancreatic development by intercellular signals. Biochemical Society Transactions. 36(3). 276–279. 4 indexed citations
14.
Guillemain, Ghislaine, et al.. (2007). Glucose Is Necessary for Embryonic Pancreatic Endocrine Cell Differentiation. Journal of Biological Chemistry. 282(20). 15228–15237. 53 indexed citations
15.
Guillemain, Ghislaine, et al.. (2007). Mechanisms of Checkpoint Kinase Rad53 Inactivation after a Double-Strand Break in Saccharomyces cerevisiae. Molecular and Cellular Biology. 27(9). 3378–3389. 52 indexed citations
16.
Guillemain, Ghislaine, et al.. (2004). Importin beta1 mediates the glucose-stimulated nuclear import of pancreatic and duodenal homeobox-1 in pancreatic islet beta-cells (MIN6). Biochemical Journal. 378(1). 219–227. 21 indexed citations
17.
Cassany, Aurélia, et al.. (2003). A Karyopherin α2 Nuclear Transport Pathway is Regulated by Glucose in Hepatic and Pancreatic Cells. Traffic. 5(1). 10–19. 20 indexed citations
18.
Guillemain, Ghislaine, María José Muñoz-Alonso, Aurélia Cassany, et al.. (2002). Karyopherin α2: a control step of glucose-sensitive gene expression in hepatic cells. Biochemical Journal. 364(1). 201–209. 40 indexed citations
19.
Guillemain, Ghislaine, M. Loizeau, Martine Pinçon‐Raymond, Jean Girard, & Armelle Leturque. (2000). The large intracytoplasmic loop of the glucose transporter GLUT2 is involved in glucose signaling in hepatic cells. Journal of Cell Science. 113(5). 841–847. 60 indexed citations
20.
Muñoz-Alonso, María José, Ghislaine Guillemain, Nadim Kassis, et al.. (2000). A Novel Cytosolic Dual Specificity Phosphatase, Interacting with Glucokinase, Increases Glucose Phosphorylation Rate. Journal of Biological Chemistry. 275(42). 32406–32412. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026